{"id":"placebo-then-darvocet-then-opana","safety":{"commonSideEffects":[{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Constipation"},{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Drowsiness"},{"rate":null,"effect":"Respiratory depression"}]},"_chembl":{"chemblId":"CHEMBL1200794","moleculeType":"Small molecule","molecularWeight":"337.80"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Darvocet (propoxyphene/acetaminophen) and Opana (oxymorphone) are both opioid receptor agonists that bind to mu-opioid receptors in the central nervous system to reduce pain perception. The trial design uses placebo as a control to assess the efficacy and safety of these marketed opioid medications in a specific patient population.","oneSentence":"This is a clinical trial sequence comparing placebo against two opioid analgesics (Darvocet and Opana) for pain relief.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:01:23.713Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Moderate to severe pain (trial indication not fully specified)"}]},"trialDetails":[{"nctId":"NCT00652093","phase":"PHASE4","title":"Lumbar Stenosis Outcomes Research II","status":"TERMINATED","sponsor":"University of Rochester","startDate":"2008-03","conditions":"Lumbar Spinal Stenosis","enrollment":24}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["opana: oxymorphone HCL","darvocet: propoxyphene/acetaminophen","placebo: inactive drug"],"phase":"marketed","status":"active","brandName":"Placebo then darvocet then opana","genericName":"Placebo then darvocet then opana","companyName":"University of Rochester","companyId":"university-of-rochester","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This is a clinical trial sequence comparing placebo against two opioid analgesics (Darvocet and Opana) for pain relief. Used for Moderate to severe pain (trial indication not fully specified).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}